gemfibrozil has been researched along with Genetic Predisposition in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP11B2." | 6.69 | Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. ( Hautanen, A; Kayes, KM; Kupari, M; Manninen, V; Mänttäri, M; Rosenfeld, S; Tenkanen, L; Toivanen, P; White, PC, 1999) |
| "Since dyslipidemia is common in diabetes and is associated with increased cardiovascular risk, we tested the hypothesis that Thr-54 is associated with increased cardiovascular risk in patients with diabetes." | 2.73 | Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT). ( Bloomfield, H; Brousseau, ME; Collins, D; Georgopoulos, A; O'Connor, JJ; Ordovas, JM; Robins, SJ; Schaefer, EJ, 2007) |
| "Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP11B2." | 2.69 | Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. ( Hautanen, A; Kayes, KM; Kupari, M; Manninen, V; Mänttäri, M; Rosenfeld, S; Tenkanen, L; Toivanen, P; White, PC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peloso, GM | 1 |
| Demissie, S | 1 |
| Collins, D | 2 |
| Mirel, DB | 1 |
| Gabriel, SB | 1 |
| Cupples, LA | 1 |
| Robins, SJ | 2 |
| Schaefer, EJ | 2 |
| Brousseau, ME | 2 |
| Georgopoulos, A | 1 |
| Bloomfield, H | 1 |
| Ordovas, JM | 1 |
| O'Connor, JJ | 1 |
| Hautanen, A | 1 |
| Toivanen, P | 1 |
| Mänttäri, M | 1 |
| Tenkanen, L | 1 |
| Kupari, M | 1 |
| Manninen, V | 1 |
| Kayes, KM | 1 |
| Rosenfeld, S | 1 |
| White, PC | 1 |
| Schmitz, G | 1 |
| Lackner, KJ | 1 |
| Flavell, DM | 1 |
| Jamshidi, Y | 1 |
| Hawe, E | 1 |
| Pineda Torra, I | 1 |
| Taskinen, MR | 1 |
| Frick, MH | 1 |
| Nieminen, MS | 1 |
| Kesäniemi, YA | 1 |
| Pasternack, A | 1 |
| Staels, B | 1 |
| Miller, G | 1 |
| Humphries, SE | 1 |
| Talmud, PJ | 1 |
| Syvänne, M | 1 |
1 review available for gemfibrozil and Genetic Predisposition
| Article | Year |
|---|---|
[Low HDL-cholesterol].
Topics: Cholesterol, HDL; Coronary Disease; Gemfibrozil; Genetic Predisposition to Disease; Humans; Hypolipi | 2000 |
2 trials available for gemfibrozil and Genetic Predisposition
| Article | Year |
|---|---|
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).
Topics: Aged; Codon; Diabetes Mellitus; Dyslipidemias; Fatty Acid-Binding Proteins; Gemfibrozil; Genetic Pre | 2007 |
Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.
Topics: Adult; Aldosterone; Alleles; Baroreflex; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; C | 1999 |
2 other studies available for gemfibrozil and Genetic Predisposition
| Article | Year |
|---|---|
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
Topics: Aged; Alleles; Case-Control Studies; Cholesterol, HDL; Coronary Disease; Gemfibrozil; Genetic Predis | 2010 |
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
Topics: Aged; Alleles; Amino Acid Substitution; Arteriosclerosis; Clinical Trials as Topic; Cohort Studies; | 2002 |